FTC Considering Litigation In Lieu Of Divestiture For Drug Chain Mergers
This article was originally published in The Tan Sheet
Executive Summary
The Federal Trade Commission is contemplating using antitrust litigation instead of its traditional strategy of requiring pharmacy chains to divest store locations in a merger, FTC Bureau of Competition Assistant Director of the Office of Policy & Evaluation David Balto told the National Association of Chain Drug Stores.
You may also be interested in...
FTC Public Workshop On Slotting Issues Urged By Senate Committee
A Federal Trade Commission public workshop to discuss the practice of slotting in retail outlets is suggested by the Senate Committee on Small Business in an Oct. 20 letter to the commission.
FTC Public Workshop On Slotting Issues Urged By Senate Committee
A Federal Trade Commission public workshop to discuss the practice of slotting in retail outlets is suggested by the Senate Committee on Small Business in an Oct. 20 letter to the commission.
FTC Public Workshop On Slotting Issues Urged By Senate Committee
A Federal Trade Commission public workshop to discuss the practice of slotting in retail outlets is suggested by the Senate Committee on Small Business in an Oct. 20 letter to the commission.